Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Media News - June 13, 2023 Category: Pharmaceuticals Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Investor Update - June 13, 2023 Category: Pharmaceuticals Source Type: news
Study links viral infections to Alzheimer ’s, Parkinson’s—with many caveats
A massive data mining study has found numerous associations between common viruses like the flu and devastating neurodegenerative disorders such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). The findings expand on previous research linking individual viruses to neurological diseases. But experts caution that the study, which relied on electronic medical records rather than biological samples, merely describes correlations and doesn’t prove causation.
Still, it’s “really exciting,” says Kristen Funk, a neuroimmunologist who studi...
Source: ScienceNOW - January 19, 2023 Category: Science Source Type: news
Why Many Older Women Are Getting Pap Tests They Don ’t Need
Women over 65 are being screened for cervical cancer in diminishing numbers. But some are reluctant to give up the tests. (Source: NYT Health)
Source: NYT Health - December 18, 2022 Category: Consumer Health News Authors: Paula Span Tags: Tests (Medical) Cancer Cervix Research Women and Girls Elderly Human Papillomavirus (HPV) Preventive Medicine United States Preventive Services Task Force Source Type: news
Battling the Twin Challenge of HIV and Cervical Cancer
A community health worker spreads the message of screening for cervical cancer along with HIV. Credit: Joyce Chimbi/IPSBy Joyce ChimbiNairobi, Dec 6 2022 (IPS) Damaris Anyango* was recently discharged from Kenyatta National Hospital, battling the twin challenge of cervical cancer and HIV. She is 50 years old and was diagnosed with HIV nearly ten years ago.
Despite the heightened risk of developing cervical cancer due to the underlying HIV-positive condition, her first cervical cancer screening was undertaken three years ago.
“It has been a big challenge dealing with HIV and cervical cancer. When I was told that my HIV te...
Source: IPS Inter Press Service - Health - December 6, 2022 Category: International Medicine & Public Health Authors: Joyce Chimbi Tags: Africa Editors' Choice Featured Gender Headlines Health TerraViva United Nations Women's Health IPS UN Bureau IPS UN Bureau Report Kenya Source Type: news
The Race to Make a Vaccine for Breast Cancer
When Karen Lynch was diagnosed with breast cancer at age 44, it was a shock, but not a complete surprise. “My family history is just riddled with cancer; my father had prostate cancer and died from stomach and esophageal cancer, and his five sisters passed from breast cancer,” she says. “My mother died from pancreatic cancer.” It was 1996, and genetic testing was not as routine as it is now, so it wasn’t until nine years after her diagnosis and treatment with lumpectomy and radiation that Lynch learned she carried the BRCA1 mutation, which increases her risk of breast cancer and ovarian cancer...
Source: TIME: Health - October 6, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer feature Frontiers of Medicine 2022 healthscienceclimate sponsorshipblock Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Basel, 21 July 2022Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follic...
Source: Roche Media News - July 21, 2022 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche achieves good results in the first six months of 2022
Group sales up 5%1 at constant exchange rates (CER) and 5% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for new medicines to treat severe diseases; as expected, the impact of biosimilars slows down furtherDiagnostics Divisionsales grow 11%; ongoing strong base business; demand for COVID-19 tests is expected to decline in the second half of the yearIFRSnet income increases by 12% (12% in Swiss francs), whilecore earnings per share are up 11%Highlights in the second quarter:EU approvals ofPolivy (first-line treatment for aggressive form of blood cancer),Lunsumio (follicular lymphoma) andT...
Source: Roche Investor Update - July 21, 2022 Category: Pharmaceuticals Source Type: news
Reducing sexually transmitted infections [NG221], NICE (published 15th June 2022)
Guideline covers interventions to prevent sexually transmitted infections (STIs) in people from 16yrs age. It aims to reduce the transmission of all STIs, including HIV,& includes ways to help increase uptake of STI testing& vaccines for human papillomavirus& hepatitis A&B. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 16, 2022 Category: Consumer Health News Source Type: news
Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by infection with Human Papillomavirus (HPV).1Nearly nine out of 10 women who die from cervical cancer live in low- and middle-income countries.2For patients living in areas with limited healthcare resources, increasing access to screening and decreasing barriers to sample collection are keys to ultimately preventing this disease.Roche ’s HPV self sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at a healthcare...
Source: Roche Investor Update - June 16, 2022 Category: Pharmaceuticals Source Type: news
Roche launches human papillomavirus (HPV) self-sampling solution, expanding cervical cancer screening options
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by infection with Human Papillomavirus (HPV).1Nearly nine out of 10 women who die from cervical cancer live in low- and middle-income countries.2For patients living in areas with limited healthcare resources, increasing access to screening and decreasing barriers to sample collection are keys to ultimately preventing this disease.Roche ’s HPV self sampling solution expands access to HPV screening options by enabling patients to privately collect their sample while at a healthcare...
Source: Roche Media News - June 16, 2022 Category: Pharmaceuticals Source Type: news
5-Year Interval for Cervical Cancer Screening Safe in HPV-Negative Women
(MedPage Today) -- Women ages 24 to 49 who initially test negative for the human papillomavirus (HPV) can be safely screened for cervical cancer at 5-year intervals, according to results from a U.K. study.
Using data from the first and second... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 3, 2022 Category: Hematology Source Type: news
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Media News - May 12, 2022 Category: Pharmaceuticals Source Type: news
Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
Almost half of the world ’s population has no or limited access to diagnosticsThis situation is especially acute in low- and middle-income countries (LMICs) where diagnostics plays a critical role for treating and containing the spread of infectious diseases such as Tuberculosis (TB) and HIVNew partnership between Roche and the Global Fund supports low- and middle-income countries in broadening access to diagnostics, helping millions of previously undiagnosed people with TB and HIV get diagnosed and eventually treatedBasel, 12 May 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Globa...
Source: Roche Investor Update - May 12, 2022 Category: Pharmaceuticals Source Type: news
Hope for cancer patients
University of Edinburgh researchers discovered the test, known as a liquid biopsy, can accurately predict if cancer caused by human papillomavirus (HPV) is going to come back. (Source: the Mail online | Health)
Source: the Mail online | Health - May 1, 2022 Category: Consumer Health News Source Type: news